Ajanta Pharma Peer Comparison

Snapshot Summary

Ajanta Pharma Ltd. demonstrates strong profitability metrics compared to its peers, with solid growth in revenue and EPS. It has a favorable debt-to-equity ratio, positioning it well in the pharmaceuticals sector. However, while it is a strong performer, certain peers also show significant strengths, especially in growth and valuation metrics.

• Ajanta Pharma has the highest revenue growth YoY among peers.
• Strong profitability indicated by a high ROE and profit margins.
• The company maintains a low debt-to-equity ratio, reflecting financial stability.
• Certain peers exhibit higher growth trajectories, particularly in EPS and revenue growth over three years.

• Dr. Reddy's Laboratories Ltd.: Highest overall profitability with strong ROE, ROA, and low valuations.
• Cipla Ltd.: Strong revenue growth and attractive valuation metrics.
• Mankind Pharma Ltd.: High revenue growth with solid profitability metrics.

Stock	CMP	Market Cap	P/E	ROE (%)	ROCE (%)	Debt/Equity
AJANTPHARM	₹2,539.40	₹30,786.01Cr	33.10	25.06%	32.87%	0.00
SUNPHARMA	₹1,706.40	₹4,09,626.46Cr	39.49	16.16%	19.89%	0.03
DIVISLAB	₹6,804.00	₹1,80,668.62Cr	78.35	15.35%	20.45%	0.00
TORNTPHARM	₹3,628.30	₹1,20,456.12Cr	60.17	26.46%	27.32%	0.40
CIPLA	₹1,511.50	₹1,22,102.70Cr	22.44	16.63%	22.77%	0.01
DRREDDY	₹1,196.00	₹99,965.86Cr	17.32	18.61%	23.25%	0.14
ZYDUSLIFE	₹981.05	₹98,057.50Cr	21.45	21.08%	26.06%	0.13

Explore

Watchlists

Command Palette

Ajanta Pharma Peer Comparison

Snapshot Summary